Source: TheMarketsDaily

Dermira: Reviewing Dermira (NASDAQ:DERM) and Neurotrope (NASDAQ:NTRP

Dermira (NASDAQ:DERM) and Neurotrope (NASDAQ:NTRP) are both small-cap medical companies, but which is the superior investment?

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Andrew Hotchkiss's photo - CEO of Dermira

CEO

Andrew Hotchkiss

CEO Approval Rating

81/100

Read more